BRAZIL – FOLIUM Science’s innovative feed additive, BiomElix® One, recently gained approval from Brazil’s Ministry of Agriculture (MAPA).
This inclusion in Brazil’s Positive List of Feed Ingredients marks a significant milestone, offering a cutting-edge solution for managing Salmonella bacteria in poultry while aligning with the global push for antibiotic-free livestock production.
BiomElix® One is powered by FOLIUM Science’s revolutionary Guided Biotics® platform, a CRISPR-Cas-based technology that selectively targets harmful microbes while preserving beneficial ones.
By enhancing the balance of the gut microbiome, the product improves poultry performance and promotes animal welfare.
This breakthrough aligns with Brazil’s focus on sustainable agriculture, particularly in reducing antimicrobial resistance (AMR) through innovative feed solutions.
Ed Fuchs, CEO of FOLIUM Science, emphasised the product’s transformative potential: “This approval underscores our expertise in CRISPR technology and represents a pivotal step for the animal nutrition industry. BiomElix® One supports the industry’s goals to meet consumer demand for antibiotic-free meat.”
Non-GMO endorsement and strategic importance
Prior to MAPA’s approval, the Brazilian National BioSafety Committee (CTNBio) certified BiomElix® One as non-GMO under its ‘new breeding technique’ framework.
This endorsement highlights the product’s ability to naturally enhance microbiome pathways without disrupting gut balance, a key advantage in maintaining sustainable livestock farming practices.
As one of the world’s largest producers of poultry, beef, and pork, Brazil presents a critical market for this innovation.
BiomElix® One is expected to address several challenges in the industry, including improving feed efficiency, reducing environmental impact, and combating AMR. These benefits reinforce Brazil’s leadership in sustainable agriculture.
With regulatory approval secured, FOLIUM Science plans to collaborate with strategic partners for large-scale field trials across Brazil. These trials aim to validate the product’s efficacy in real-world conditions and further demonstrate its potential to revolutionise animal nutrition.
“This is the dawn of next-generation probiotics,” noted Fuchs. “The approval of BiomElix® One is a significant milestone, but the journey to maximise its impact on sustainable agriculture has just begun.”
BiomElix® One’s approval is a triumph for FOLIUM Science and a major step forward for the animal feed industry.
By leveraging advanced biotechnology, the product offers a promising solution to modern challenges, paving the way for a healthier, more sustainable future in global livestock farming.
Sign up HERE to receive our email newsletters with the latest news updates and insights from Africa and the World and follow us on our WhatsApp channel for updates.
Be the first to leave a comment